The role of extracellular matrix in small-cell lung cancer
- 1 July 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (7) , 437-442
- https://doi.org/10.1016/s1470-2045(00)00421-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesivenessNature, 1997
- Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancerEuropean Journal Of Cancer, 1996
- Integrins: Emerging Paradigms of Signal TransductionAnnual Review of Cell and Developmental Biology, 1995
- Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cellsInternational Journal of Cancer, 1995
- Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell linesEuropean Journal Of Cancer, 1994
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994
- Disruption of epithelial cell-matrix interactions induces apoptosisThe Journal of cell biology, 1994
- Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration.The Journal of Experimental Medicine, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988